COCH Insider Trading Activity and SEC Form 4 Filings
COCH insider trading summary
Over the past 12 months, insiders at Envoy Medical, Inc. (COCH) reported 6 open-market purchases worth $8.2M by 6 insiders and no sales on SEC Form 4. Net insider buying was $8.2M.
Latest COCH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 12, 2026 | Robert Potashnick | Interim CFO | Buy | $85K (212,500 @ $0.40) |
| Feb 12, 2026 | Brent T. Lucas | Chief Executive Officer | Buy | $25K (62,500 @ $0.40) |
| Feb 12, 2026 | Mona Chetan Patel | Director | Buy | $125K (312,500 @ $0.40) |
| Feb 12, 2026 | Glen A Taylor | 10% Owner | Buy | $7.5M (18,750,000 @ $0.40) |
| Feb 12, 2026 | Susan Kantor | Director | Buy | $38K (96,150 @ $0.40) |
| Feb 12, 2026 | Charles Brynelsen | Director | Buy | $400K (1,000,000 @ $0.40) |
| Jun 11, 2025 | Mona Chetan Patel | Director | Buy | $4K (2,500 @ $1.47) |
| Jun 6, 2025 | Mona Chetan Patel | Director | Buy | $15K (10,000 @ $1.46) |
| May 27, 2025 | Charles Brynelsen | Director | Buy | $58K (35,000 @ $1.65) |
| May 23, 2025 | Charles Brynelsen | Director | Buy | $21K (13,000 @ $1.64) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.